BTIG analyst Mark Massaro reiterated a Buy rating on Personalis (PSNL - Research Report) yesterday and set a price target of $8.00. The company's shares closed yesterday at $2.70.Massaro covers the Healthcare sector, focusing on stocks such as Castle Biosciences, T2 Biosystems, and Natera. According to TipRanks, Massaro has an average return of -4.3% and a 40.28% success rate on recommended stocks. In addition to BTIG, Personalis also received a Buy from H.C. Wainwright's Swayampakula Ramakanth in a report issued yesterday. However, on the same day, Needham maintained a Hold rating on Personalis (NASDAQ: PSNL).
https://www.tipranks.com/news/blurbs/btig-sticks-to-their-buy-rating-for-personalis-psnl?utm_source=advfn.com&utm_medium=referral
Personalis (NASDAQ:PSNL)
Historical Stock Chart
From Oct 2023 to Nov 2023 Click Here for more Personalis Charts.
Personalis (NASDAQ:PSNL)
Historical Stock Chart
From Nov 2022 to Nov 2023 Click Here for more Personalis Charts.